These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35155284)

  • 21. Pigsties near dwellings as a potential risk factor for the prevalence of Japanese encephalitis virus in adult in Shanxi, China.
    Ren X; Fu S; Dai P; Wang H; Li Y; Li X; Lei W; Gao X; He Y; Lv Z; Cheng J; Wang G; Liang G
    Infect Dis Poverty; 2017 Jun; 6(1):100. PubMed ID: 28592296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
    Hegde NR; Gore MM
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Japanese encephalitis and Japanese encephalitis virus in mainland China.
    Zheng Y; Li M; Wang H; Liang G
    Rev Med Virol; 2012 Sep; 22(5):301-22. PubMed ID: 22407526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).
    Appaiahgari MB; Vrati S
    Expert Opin Biol Ther; 2012 Sep; 12(9):1251-63. PubMed ID: 22775524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Past, present, and future of Japanese encephalitis.
    Erlanger TE; Weiss S; Keiser J; Utzinger J; Wiedenmayer K
    Emerg Infect Dis; 2009 Jan; 15(1):1-7. PubMed ID: 19116041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of Japanese encephalitis in India: a reality.
    Kabilan L
    Indian J Pediatr; 2004 Aug; 71(8):707-12. PubMed ID: 15345871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and control of Japanese encephalitis.
    Igarashi A
    World Health Stat Q; 1992; 45(2-3):299-305. PubMed ID: 1334301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of Japanese encephalitis in Asia: the time is now.
    Hills S; Martin R; Marfin A; Fischer M
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):901-4. PubMed ID: 24927959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
    Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
    BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Khan SA; Choudhury P; Kakati S; Doley R; Barman MP; Murhekar MV; Kaur H
    Vaccine; 2021 Aug; 39(35):4973-4978. PubMed ID: 34325931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travellers.
    Lindquist L
    J Travel Med; 2018 May; 25(suppl_1):S3-S9. PubMed ID: 29718434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.
    Schuh AJ; Ward MJ; Leigh Brown AJ; Barrett AD
    J Virol; 2014 Apr; 88(8):4522-32. PubMed ID: 24501419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Japanese encephalitis in the Philippines: a systematic review.
    Lopez AL; Aldaba JG; Roque VG; Tandoc AO; Sy AK; Espino FE; DeQuiroz-Castro M; Jee Y; Ducusin MJ; Fox KK
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003630. PubMed ID: 25794009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
    Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
    Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case series of three US adults with Japanese encephalitis, 2010-2012.
    Hills SL; Stoltey J; Martínez D; Kim PY; Sheriff H; Zangeneh A; Eilerman SR; Fischer M
    J Travel Med; 2014; 21(5):310-3. PubMed ID: 24861145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New strains of Japanese encephalitis virus circulating in Shanghai, China after a ten-year hiatus in local mosquito surveillance.
    Fang Y; Zhang Y; Zhou ZB; Xia S; Shi WQ; Xue JB; Li YY; Wu JT
    Parasit Vectors; 2019 Jan; 12(1):22. PubMed ID: 30626442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
    Muniaraj M; Rajamannar V
    Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Japanese encephalitis surveillance and immunization--Asia and the Western Pacific, 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):658-62. PubMed ID: 23965828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.